Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Baxter
US Department of Justice
Teva
Chubb
AstraZeneca
US Army
Deloitte
Julphar

Generated: June 18, 2018

DrugPatentWatch Database Preview

NAVELBINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Navelbine, and what generic alternatives are available?

Navelbine is a drug marketed by Pierre Fabre and is included in one NDA.

The generic ingredient in NAVELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
Drug patent expirations by year for NAVELBINE
Pharmacology for NAVELBINE
Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Synonyms for NAVELBINE
486V221
5'-anhydrovinblastine
71486-22-1
AB01275493-01
AB01566877_01
ABP000672
AKOS024457606
Ambap71486-22-1
ANX-530
Aspidospermidine-3-carboxylic acid
Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3b
AT-7140
BT001187
C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-
C45H54N4O8
CCG-208616
CHEBI:480999
CHEMBL553025
CS-0212
D01HTL
D08680
DTXSID8040640
Eunades
Exelbine
FT-0657343
GBABOYUKABKIAF-IELIFDKJSA-N
GTPL7105
HMS2090E13
HSDB 7665
HY-12053
K210
KW 2307
KW 2307 base
KW-2307
methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carbo
MolPort-006-823-869
Navelbin
Navelbine (TN)
Navelbine base
NCGC00165966-03
Nor-5'-anhydrovinblastine
noranhydrovinblastine tartrate
NVB
Q6C979R91Y
SCHEMBL4765
SDP-012
UNII-Q6C979R91Y
Vinorelbin
VINORELBIN DITARTRATE
Vinorelbina
Vinorelbina [Spanish]
vinorelbine
Vinorelbine (INN)
Vinorelbine [INN:BAN]
Vinorelbine Ditartarate
Vinorelbine(Navelbine)
Vinorelbine(Navelbine)/
Vinorelbinum
Vinorelbinum [Latin]
ZINC85536958

US Patents and Regulatory Information for NAVELBINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pierre Fabre NAVELBINE vinorelbine tartrate INJECTABLE;INJECTION 020388-001 Dec 23, 1994 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
Deloitte
Argus Health
Colorcon
Queensland Health
Cantor Fitzgerald
Federal Trade Commission
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.